We measured the concentration of endogenous digitalislike factors (EDLFs) inmilkor colostrum of women during nursing on different days after delivery. EDLF concentrations were assayed by a solid-phase RIA involving antidigoxin antibodies and by a radioreceptor assay (RRA) involving human placenta Na/K-ATPase.
We measured the concentration of endogenous digitalislike factors (EDLFs) inmilkor colostrum of women during nursing on different days after delivery. EDLF concentrations were assayed by a solid-phase RIA involving antidigoxin antibodies and by a radioreceptor assay (RRA) involving human placenta Na/K-ATPase.
The mean (SD) EDLF concentrations as measured by RIA were 35.6 (19.4) ng of digoxin equivalents per liter inmilksamples (n = 37) and 61.3 (12.5) ng/L in colostrum samples (n = 5); the mean EDLF concentration as measured by RRA in milk samples (n = 11) was 573 (717) ng/L (range 0-2098). EDLF concentration in milk is greater than circulating concentrations in healthy adults but is comparable with serum concentration in the third trimester of pregnancy. In milk and serum samples (n = 8) collected at the same time, heating and (or) extracting with Sep-Pak C18 cartridges before the AlA produced significantly different EDLF values from those in untreated serum (P <0.001) and milk (P = 0.035). EDLF in milk appeared to be not bound or weakly bound to milk protein, as indicated by the fact that boiling did not increase the digoxin-like immunoreactivity.
AddftlonalKeyphras.s:
Endogenous factors with immunological properties and biological activity similar to digitalis drugs (endogenous digitalis-like factors, EDLFs) have been found in tissues and body fluids of animals and humans (1) (2) (3) (4) (5) . EDLF concentrations are increased in amniotic fluid, cord blood, serum and urine of pregnant women, and neonates (2, 5) . Recently, digoxin-like materials have been detected in saliva of pregnant women (6) and in human breast cyst fluids (7). The biochemical characteristics and physiological functions of EDLF are not well defined, but EDLF may play a role in the regulation of fluid volume and electrolytes in newborns and in the pathogenesis of arterial hypertension and eclampsia in pregnancy (2, 5) . EDLF-like material may also regulate electrolyte composition of breast cyst fluids and indicate risk of developing breast cancer (7) .
To establish whether EDLFs are normal constituents of human milk, we measured EDLF in milk or cobstrum collected from women during nursing at different days after delivery by an RIA and by a radioreceptor assay (RRA). By RIA we processed 59 specimens of human milk, 5 of colostrum, and 8 of serum collected from 24 women during nursing at different days after delivery (from 2 to 30 days); 11 samples of milk were also assayed by RRA. All milk and colostrum specimens were centrifuged (2000 x g for 10 mm), and the lipidic phases on top were discarded.
MaterIals and Methods

RIA
By the RIA, we assayed the colostrurn specimens and 37 milk specimens directly, without preliminary extraction or purification. We assayed the serum and milk specimens from eight of the nursing women after the samples were diluted threefold with distilled water, To improve the precision of the RIA, we assayed 22 milk samples that had been concentrated twofold by lyophilization; the mean EDLF concentration was 44.5 (SD 8.0) ng/L.
Results of the dilution test performed on a lyophilized and concentrated milk pool are reported in Figure 1. A linear relationship was found between the volume assayed and the iinmunoreactivity measured by RIA for as much as a fourfold concentration induced by lyophilization; the measurement was affected by higher concentrations.
DIscussion
Our data indicate that endogenous factors with immunological and biological activity similar to digitalis drugs are normal constituents of human milk. We assessed the presence of substances with immunological properties similar to glycoside cardioactive drugs with a solid-phase RIA method (as cross-reactivity with antidigoxin antibodies) and assayed digitalis-like biological activity by using the inhibition effect on '25I-labeled digoxin binding to human placental Na/K-ATPase. As previously shown (12,17,18 (7) for breast cyst fluids. Moreover, according to the hypothesis that EDLFs may actively regulate electrolyte-fluid balance in newborns and infants (5) , EDLFs could be secreted (or concentrated) in human milk to provide infants with an exog- 
